https://news.augustaheadlines.com/story/576666/chronic-obstructive-pulmonary-disease-pipeline-shows-strong-momentum-as-65-pharma-companies-in-the-race-delveinsight.html 2026-06-05T03:40:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/576665/cart-pipeline-expands-as-180-companies-driving-innovation-in-the-therapeutics-delveinsight.html 2026-06-05T03:34:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/576664/atopic-dermatitis-pipeline-shows-potential-with-active-contributions-from-100-key-companies-delveinsight.html 2026-06-05T03:26:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/576663/alzheimers-disease-pipeline-accelerates-as-200-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight.html 2026-06-05T03:20:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/576662/next-generation-immunotherapies-market-size-expected-to-witness-significant-growth-by-2034-estimates-delveinsight.html 2026-06-05T03:14:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/576661/alopecia-areata-pipeline-gains-momentum-18-companies-lead-the-charge-in-pioneering-new-treatments-delveinsight.html 2026-06-05T03:04:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/576660/diabetic-neuropathic-pain-market-is-projected-to-grow-significantly-by-2034-owing-to-the-launch-of-emerging-therapies-delveinsight.html 2026-06-05T02:58:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/576659/egfr-inhibitorsinduced-skin-disorders-market-is-projected-to-grow-by-2036-owing-to-the-rising-use-of-targeted-cancer-therapies-and-emerging-novel-treatment-approaches-delveinsight.html 2026-06-05T02:52:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/576658/actinic-keratosis-market-is-projected-to-grow-by-2036-owing-to-the-rising-disease-burden-and-emerging-novel-therapies-delveinsight.html 2026-06-05T02:46:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/576657/gene-and-cell-therapies-targeting-cns-disorders-market-expected-to-experience-accelerated-growth-and-market-evolution-by-2036-delveinsight-brainstorm-cell-therapeutics-meiragtx-voyager-thera.html 2026-06-05T02:38:03+00:00 daily 1.0